Commentary
Enhancement drugs: are there limits to what we should enhance and why?
-
Correspondence: Morten Hesse mh@crf.au.dk
BMC Medicine 2010, 8:50 doi:10.1186/1741-7015-8-50
Accesses
- Last 30 days: 45 accesses
- Last 365 days: 520 accesses
- All time: 3655 accesses